
China Approves First Domestic 9-Valent HPV Vaccine
China approves its first domestically developed 9-valent HPV vaccine, a major step in public health and medical innovation offering broader protection against cervical cancer.
News & Insights Across Asia
China approves its first domestically developed 9-valent HPV vaccine, a major step in public health and medical innovation offering broader protection against cervical cancer.
China approves its first domestically developed nine-valent HPV vaccine, enhancing cervical cancer prevention efforts and expanding access to advanced medical solutions.
Chinese mental health expert Dr. Wang Huali receives WHO’s Sheikh Sabah Al-Ahmad Prize for advancing dementia care and healthy aging initiatives globally.
China’s new 3-year health initiative targets obesity and diabetes through lifestyle education and expert-backed strategies for weight management.
70% of Chinese adults prioritize weight loss, driving national health campaigns and dietary shifts to combat rising obesity rates.
Beijing’s JD Health campaign ties cash rewards to weight loss, reflecting China’s growing emphasis on health-driven lifestyle changes over aesthetic goals.
China releases updated anti-cancer handbook emphasizing prevention through lifestyle changes, BMI management, and public health strategies during National Cancer Prevention Week.
China achieves over 95% measles vaccination coverage, nearing elimination through coordinated public health efforts and real-time outbreak monitoring systems.
China reduces tuberculosis incidence and mortality by 30% over a decade, outpacing global averages through coordinated public health strategies.
New research in China connects regular exercise with enhanced sleep quality, aligning with national health initiatives targeting obesity and holistic wellness.
China’s average life expectancy reaches 79 years in 2024, reflecting decades of healthcare advancements and economic stability, according to official reports.